£10.87m
+9%vs Mar 2025Active09496393Private limited companyAbingdon
REPLIMUNE LIMITED
Significant control: Replimune Group, Inc. (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Replimune Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
REPLIMUNE LIMITED is an active private limited company (company number 09496393) incorporated on 18 March 2015, registered in Abingdon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest full accounts cover the period ending 31 March 2026, showing net assets of £10.87m and cash of £4.44m, with 79 employees on average. Net assets rose 9% on the prior period (£9.96m). Across the last 3 periods on record the net-asset trend is volatile.
Peer position · net assets
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Replimune Group, Inc.
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 March 201511 yrs ago
- Next accounts due
- 31 December 2027in 434 days
- Confirmation statement due
- 1 April 2027in 160 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Full
- Size band
- MediumCompanies Act thresholds
05
Financials
£4.44m
+85%vs Mar 2025Not reported
79
+16%vs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £10.87m | £4.44m | £793k | £28.16m | — | −£247.67m | 79 |
| 31 March 2025 | £9.96m | £2.39m | £1.11m | £43.62m | — | −£214.69m | 68 |
| 31 March 2024 | £10.68m | £1.75m | £639k | £84.37m | — | −£201.64m | 65 |
| 31 March 2023 | — | — | — | — | — | — | — |
Current ratio0.31Current assets ÷ creditors within one year
Cash per employee£56kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £10,874,053 at 31 March 2026
- Current assets below creditors within one yearCurrent ratio 0.31
- Cash at bank of £50,000 or moreCash £4,439,720
- Three or more accounting periods on record4 periods on record
- Incorporated five or more years agoIncorporated 18 March 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 434 days
- Confirmation statement duein 160 days
- Accounts period endNet assets £10.87m · full accounts
- Accounts period endNet assets £9.96m · full accounts
- Accounts period endNet assets £10.68m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in Oxford
- MOLECULAR WAREHOUSE LTD.Oxford · inc. Mar 2015
- SEROX LIMITEDWitney · inc. Feb 2015
- PETER KNAPP QA LIMITEDWheatley · inc. Feb 2015
- ARCTURIS DATA HOLDINGS LIMITEDKidlington · inc. Feb 2015
- BIOME OXFORD LIMITEDThame · inc. Apr 2015
- GLIOTHERAPY LIMITEDOxford · inc. May 2015
All companies incorporated on 18 March 2015 · in Mar 2015.
09
Reminders for REPLIMUNE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.